CNS Pharmaceuticals, Inc.
CNSP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001729427
In the last 90 days, CNS Pharmaceuticals, Inc. insiders filed 1 open-market purchase and 0 sales; 11 institutions reported holding it in 13F filings for Q2 2026, worth $1.34M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding CNS Pharmaceuticals, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 20 | 20 | 0 |
| Shares | 1.35M | 967.8K | −379.0K (−28.1%) |
| Value | $2.64M | $1.44M | −$1.20M (−45.6%) |
New holders (4)
Institutions that held CNS Pharmaceuticals, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bank of New York Mellon Corp | 29,758 | $44.0K | 0.00% |
| Citadel Advisors LLC | 21,213 | $32.0K | 0.00% |
| HRT Financial LP | 16,531 | $24.0K | 0.00% |
| Migdal Insurance & Financial Holdings Ltd. | 2,058 | $3.00K | 0.00% |
Sold out (4)
Institutions that held CNS Pharmaceuticals, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Renaissance Technologies LLC | 432,109 | $847.0K |
| Two Sigma Securities, LLC | 11,061 | $22.0K |
| Integrated Advisors Network LLC | 10,700 | $21.0K |
| UBS Group AG | 4,676 | $9.00K |